Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 138 results for "claris lifesciences"

USFDA finds Claris Lifesciences plant acceptable
Money Control

Claris Lifesciences: Updates on outcome of AGM

Claris Lifesciences Ltd has submitted to BSE a copy of the proceedings of the 19th Annual General Meeting (AGM) of the Company held on June 17, 2014. Money Control, 2 weeks ago
Claris Lifesciences shares up over 3% on BSE Business Standard, 2 weeks ago
[x]  

6 images for claris lifesciences

Moneycontrol.com, 2 weeks ago
Hindu Business Line, 2 months ago
Money Control, 4 months ago
Money Control, 4 months ago
Oneindia, 6 months ago
Financial Express, 6 months ago

Carlyle exits Repco Home Finance; scores 9x return on last tranche...

Private equity firm Carlyle group LP has fully exited its investment in housing finance company Repco Home Finance for Rs 471.5 crore ($78.4 million) via open market transaction on Thursday. This exit marks a 9x return for the PE investor over a ...
 VC Circle1 week ago

Claris Lifesciences gets USFDA approval for finished dosage and API plants

Claris Lifesciences has received a report from US Food and Drug Administration (USFDA) for the inspection it conducted classifying the finished dosage plant and API plant as acceptable. Claris Lifesciences is one of the few injectables companies in ...
 Indian-Commodity2 weeks ago Claris Lifesciences gains 7%, USFDA approves API plant  Money Control2 weeks ago Claris gets USFDA report stating it's finished dosage plant  India Infoline2 weeks ago USFDA terms Claris Lifesciences Ltd's finished dosage plant and API plant as acceptable  Equity Bulls2 weeks ago

Claris shares surge as USFDA clears two plants

Claris Lifesciences, one of the largest sterile injectables pharmaceutical companies in India, surged on Wednesday after it received USFDA report stating it's finished dosage plant and API plant as acceptable. Shares ofthe companyare trading at Rs ...
 New Indian Express2 weeks ago Claris Lifesciences stock surges 3%  India Infoline2 weeks ago Pre-Budget Expectation: Claris Lifesciences  India Infoline2 weeks ago

Claris Lifesciences spurts after board OKs transferring speciality injectable biz

Claris Lifesciences jumped 5.03% to Rs 167 at 15:19 IST on BSE after the company said its board approved transferring the speciality injectable business by way of a slump sale to a wholly-owned subsidiary of the company.
 Business Standard3 weeks ago Claris Lifesciences rises after board OKs transferring speciality injectable biz  FirstWord Pharma3 weeks ago

Carlyle, Signet & OrbiMed part exit Claris Lifesciences

BY Shruti Ambavat While Carlyle has made a modest exit over a long holding period, the other investors have clocked reasonable annualized returns even as their remaining stake is underwater, as per VCCircle estimates. Private equity ...
 VC Circle1 month ago

Claris Lifesciences gains on receiving USFDA approval for finished dosage and API plants

Claris Lifesciences is currently trading at Rs. 173.00, up by 9.80 points or 6.00% from its previous closing of Rs. 163.20 on the BSE. The scrip opened at Rs. 175.00 and has touched a high and low of Rs. 175.05 and Rs. 170.00 respectively. So far ...
 Arihant Capital2 weeks ago

Union Budget Reaction - Mr. Arjun Handa - Managing Director & CEO, Claris Lifesciences

Mr. Arjun Handa - Managing Director & CEO, Claris Lifesciences The budget has drawn some broad strokes on the canvas showing the governments intent in the coming years. The budget has given additional funds to middle class and the senior citizens, ...
 Equity Bulls2 weeks ago 'Overall this was a positive budget' - Arjun Handa  Express Pharma2 weeks ago Budget 2014: Implementation of GST should be top priority of Government  Economic Times2 weeks ago
Rediff.com

Need clarity on UID and related Direct Benefit Transfer

A clear communication on the status of UID and the next course of action would go a long way in giving some direction to the initiatives started on the basis of Aadhar, especially Direct benefit transfer (DBT) of welfare payments.  Lot of investment and efforts went into these initiatives and any change will impact payment technology services providers and other stakeholders. We expect the new government to look into the issue of penalties imposed on technology firms involved in UID ...
 Rediff.com2 weeks ago
DeshGujarat

Budget, a tale of missed opportunities

Members of Federation of Gujarat Industries watch the live telecast of the Union Budget. The industry and taxation experts who gathered in Gujarat on Friday to discuss the fine-print of Union Budget, felt that it was a missed opportunity for the ...
 Indian Express2 weeks ago Gujarat based industry barons react to union budget  DeshGujarat2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less